US Patent 9597332 Sulfide alkyl compounds for HBV treatment
Patent 9597332 was granted and assigned to Novira Therapeutics on March, 2017 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 9597332 Sulfide alkyl compounds for HBV treatment
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.